COVID-19 (Corona Virus Disease) is caused by 2019-nCoV (SARS-CoV-2) which ismainly transmitted through respiratory droplets. Symptoms of COVID-19 mayappear 1-14 days after exposure and mainly include: fever, cough and shortness ofbreath.Early Corona Virus (COVID-19) diagnosis is routinely carried out by detection ofvirus with PCR-test. Since the courses of the disease are very different and the virusis very infectious, it is not sufficient to isolate only clinically conspicuous individualsfor quarantine measures. Therefore it is useful to test not only for the presence ofthe virus, but also physical response to the antigen: IgM and IgG antibodies!Early virus detection and testing of COVID-19 antibodies complement each other toimprove efficiency and monitor disease progression!

covid19

NOVEL CORONAVIRUS COVID-19    IGM ELISA           ID E-1100           96 WELLS

ELISA for the specific and qualitative detection of human IgM antibodies againstCoronavirus SARS-CoV-2 (COVID-19) in human serum.

IgM antibodies are the first immunoglobulin to be produced in response to an antigen and are primarily presentduring the early stage of the disease. They can serve as evidence of infection with Coronavirus infectious disease.

Principle: ELISA, qualitative 

Sample Type: Human serum  

Sample Volume: 20 μL  

Assay Incubation: 30 / 30 / 20 min  

Performance:Positive predictive value90%

                      Negative predictive value  79.3%

Advantages:  Specific detection of antibodies against newSARS-CoV-2 virus

                       Assay designed with “IgM capture” method

                       Results within 1.5 hours

 

NOVEL CORONAVIRUS COVID-19    IGG ELISA           ID E-1000            96 WELLS

ELISA for the specific and qualitative detection of human IgG antibodies againstCoronavirus SARS-CoV-2 (COVID-19) in human serum.

IgG antibodies are the most abundantly found immunoglobulin to be produced in response to an antigen and will bemaintained in the body after initial exposure for long term response.

Principle: ELISA, qualitative 

Sample Type: Human serum  

Sample Volume: 10 μL 

Assay Incubation: 30 / 30 / 20 min  

Performance:  Positive predictive value 100%

                          Negative predictive value100%

Advantages:  Specific detection of antibodies against newSARS-CoV-2 virus

                       SARS-CoV-2 recombinant full lengthnucleocapsid protein used

                        Results within 1.5 hours